Harbin Pharmaceutical Group Co., Ltd. announced earnings results for the half year ended June 30, 2020. For the half year, the company announced sales was CNY 4,809.380 million compared to CNY 5,516.041 million a year ago. Operating loss was CNY 262.619 million compared to operating Income of CNY 60.575 million a year ago. Net loss was CNY 333.302 million compared to CNY 42.347 million a year ago. Basic loss per share from continuing operations was CNY 0.13 compared to CNY 0.02 a year ago.